PR Newswire · Press release
AXON Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into AXON (AXON)
AI summary
Summary by Wenlo · not part of the original release
On November 6, 2026, Levi & Korsinsky, LLP announced a pending investigation into Axon Enterprise, Inc. following a November 5, 2026 reduction in the company's full-year 2026 revenue outlook to $3.61 billion to $3.63 billion. The company lowered its guidance after pulling approximately $130,000,000 in revenue tied to delayed Federal Dedrone deployments, following an earlier forecast increase on August 5, 2026. Shareholders who suffered financial losses are encouraged to contact Joseph E. Levi, Esq. at (212) 363-7500.
AI summaries can miss details: read the full release below. Not investment advice.
Original release from PR Newswire
As distributed by PR Newswire, unedited.
Axon raised its 2026 growth forecast to 32%-34% on August 5, then cut it to approximately 30% on November 5 after pulling roughly $130 million in revenue tied to three delayed Federal Dedrone deployments. Shareholders who lost money have rights.
NEW YORK, Nov. 6, 2026 /PRNewswire/ -- Ninety-two days after raising its full-year forecast, Axon Enterprise, Inc. (NASDAQ: AXON) cut its 2026 revenue outlook on November 5, 2026 to $3.61 billion to $3.63 billion. The cut removed approximately $130 million tied to three delayed Federal Dedrone counter-drone deployments, and AXON shares fell as the market reacted. If you held AXON shares when that outlook was cut and lost money, you have legal rights. Shareholders who suffered losses are encouraged to find out whether they may recover their AXON losses now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
On the August 5, 2026 second-quarter call, CFO Brittany Bagley said: "We're raising our full-year revenue guidance to a range of 32%-34%, 200 basis points above our prior range of 30%-32%." One of the three Federal Dedrone deployments, valued at approximately $30 million, was expected to contribute revenue in the third quarter. That quarter was already underway when the raise was announced. The other two deployments, totaling approximately $100 million, were expected in the fourth quarter.
The November 5 reset put full-year growth at approximately 30%. That is the low end of the 30%-32% range Axon had raised from in August. The top of the new range, $3.63 billion, sits $40 million below the bottom of the prior $3.67 billion to $3.725 billion range. Levi & Korsinsky is investigating potential securities law violations concerning whether the August guidance increase adequately reflected the timing of the Federal Dedrone deployments.
AXON shareholders who lost money after the November 5 guidance cut are encouraged to request a review of their investment losses or call Joseph E. Levi, Esq. at (212) 363-7500.
Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com
Frequently Asked Questions About the AXON Investigation
Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Axon Enterprise, Inc. made materially false or misleading statements regarding its 2026 revenue outlook and the timing of Federal Dedrone counter-drone deployments. This includes the August 5, 2026 increase in full-year revenue growth guidance to 32%-34%. On November 5, 2026, the Company disclosed that it had removed approximately $130 million tied to three delayed Federal Dedrone deployments and lowered its outlook to $3.61 billion to $3.63 billion. The stock price declined after that disclosure.
Q: When did Axon allegedly mislead investors?A: The investigation concerns statements made before the November 5, 2026 guidance reset that allegedly caused investors to purchase securities at inflated prices.
Q: Who is eligible to participate in the AXON investigation?A: Investors who purchased AXON stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What do AXON investors need to do right now?A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my AXON shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought AXON and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Q: What if I live outside the United States?A: U.S. securities investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
View original content to download multimedia:https://www.prnewswire.com/news-releases/axon-investigation-notice-levi--korsinsky-notifies-investors-of-pending-investigation-into-axon-axon-302932415.html
SOURCE Levi & Korsinsky, LLP
